U.S. markets closed
  • S&P Futures

    3,924.75
    -5.25 (-0.13%)
     
  • Dow Futures

    32,595.00
    -24.00 (-0.07%)
     
  • Nasdaq Futures

    13,023.50
    -48.25 (-0.37%)
     
  • Russell 2000 Futures

    2,258.40
    -2.90 (-0.13%)
     
  • Crude Oil

    61.47
    -0.08 (-0.13%)
     
  • Gold

    1,733.60
    -4.50 (-0.26%)
     
  • Silver

    25.67
    -0.09 (-0.36%)
     
  • EUR/USD

    1.1929
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    1.6840
    -0.0480 (-2.77%)
     
  • Vix

    18.88
    -2.07 (-9.88%)
     
  • GBP/USD

    1.3843
    -0.0021 (-0.15%)
     
  • USD/JPY

    108.7420
    -0.0780 (-0.07%)
     
  • BTC-USD

    54,872.21
    -2,033.15 (-3.57%)
     
  • CMC Crypto 200

    1,099.82
    -51.63 (-4.48%)
     
  • FTSE 100

    6,726.10
    +17.39 (+0.26%)
     
  • Nikkei 225

    29,243.44
    +69.29 (+0.24%)
     

Why GRPN Stock And ODT Stock Are Trading Lower Today

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Henry Khederian
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Groupon Inc (NASDAQ: GRPN) shares are trading lower Monday after the company announced a proposed private offering of $200 million of convertible senior notes.

Groupon acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. The company is best known for offering consumers daily deals in the form of online vouchers from local merchants.

Odonate Therapeutics Inc (NASDAQ: ODT) shares are trading lower after the company said it would discontinue the development of its Tesetaxel.

Odonate is engaged in the development of therapeutics which improve and extend the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxanes, which are widely used in the treatment of cancer including breast cancer.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.